Multimeric peptide-based PEG nanocarriers with programmable elimination properties

Biomaterials

Volumn 30, Issue 29, 2009, Pages 5649-5659

  Gunaseelan, Simi ^a   Pooyan, Shahriar ^a   Chen, Peiming ^a   Samizadeh, Mahta ^a   Palombo, Matthew S ^a   Stein, Stanley ^a   Zhang, Xiaoping ^a   Sinko, Patrick J ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b Environmental and Occupational Health Sciences Institute   (United States)

Author keywords

Disulfide; GSH dependent biodegradation; Intracellular elimination; Nanocarrier; PEG; Peptide

Indexed keywords

DISULFIDE; GSH-DEPENDENT BIODEGRADATION; INTRACELLULAR ELIMINATION; NANOCARRIER; PEG;

AMINES; BIOCHEMISTRY; DEGRADATION; DIMETHYL SULFOXIDE; ENZYME ACTIVITY; LABELS; MICROBIOLOGY; PEPTIDES; POLYDISPERSITY; POLYETHYLENE GLYCOLS;

BIODEGRADATION;

BETA ALANINE; FLUORESCEIN; GLUTATHIONE; HETERODIMER; MACROGOL; NANOCARRIER; PEPTIDE;

ARTICLE; BIOCHEMISTRY; BIODEGRADABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; PRIORITY JOURNAL; SIMULATION; STOICHIOMETRY; SYNTHESIS;

ABSORBABLE IMPLANTS; BODY FLUIDS; COATED MATERIALS, BIOCOMPATIBLE; DIMERIZATION; DRUG CARRIERS; MATERIALS TESTING; PEPTIDES; POLYETHYLENE GLYCOLS;

EID: 68549110150     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.05.068     Document Type: Article

References (42)

1. Perry C.M., and Jarvis B. Peginterferon-alpha-2a (40 kDa): a review of its use in the management of chronic hepatitis C. Drugs 61 15 (2001) 2263-2288
2. Gupta S., Jen J., Kolz K., and Cutler D. Dose selection and population pharmacokinetics of PEG-intron in patients with chronic myelogenous leukaemia. Br J Clin Pharmacol 63 3 (2007) 292-299
3. Nucci M.L., Shorr R., and Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Deliv Rev 6 2 (1991) 133-151
4. Stigsnaes P., Frokjaer S., Bjerregaard S., van de Weert M., Kingshott P., and Moeller E.H. Characterisation and physical stability of PEGylated glucagon. Int J Pharm 330 1-2 (2007) 89-98
5. Kozlowski A., and Harris J.M. Improvements in protein PEGylation: PEGylated interferons for treatment of hepatitis C. J Control Release 72 1-3 (2001) 217-224
6. Bailon P., Palleroni A., Schaffer C.A., Spence C.L., Fung W.J., Porter J.E., et al. Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. Bioconjugate Chem 12 2 (2001) 195-202
7. Wattendorf U., and Merkle H.P. PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci 97 11 (2008) 4655-4669
8. Nakaoka R., Tabata Y., Yamaoka T., and Ikada Y. Prolongation of the serum half-life period of superoxide dismutase by poly(ethylene glycol) modification. J Controlled Release 46 3 (1997) 253-261
9. Venturoli D., and Rippe B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol 288 4 (2005) F605-F613
10. Ahsan F., Rivas I.P., Khan M.A., and Torres Suarez A.I. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres - on the phagocytosis by macrophages. J Control Release 79 1-3 (2002) 29-40
11. Foged C., Brodin B., Frokjaer S., and Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298 2 (2005) 315-322
12. Thiele L., Rothen-Rutishauser B., Jilek S., Wunderli-Allenspach H., Merkle H.P., and Walter E. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?. J Control Release 76 1-2 (2001) 59-71
13. Salazar V.B.Y., Wettstein R., Cabrales P., Tsai A.G., and Intaglietta M. Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation. Biochim Biophys Acta 1784 10 (2008) 1421-1427
14. Conover C.D., Linberg R., Gilbert C.W., Shum K.L., and Shorr R.G.L. Effect of polyethylene glycol conjugated bovine hemoglobin in both top-load and exchange transfusion rat models. Artif Organs 21 10 (1997) 1066-1075
15. Knauf M.J., Bell D.P., Hirtzer P., Luo Z.P., Young J.D., and Katre N.V. Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. J Biol Chem 263 29 (1988) 15064-15070
16. Bailon P., and Berthold W. Polyethylene glycol-conjugated pharmaceutical proteins. Pharm Sci Technol Today 1 8 (1998) 352-356
17. Yamaoka T., Tabata Y., and Ikada Y. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 83 4 (1994) 601-606
18. Pooyan S., Qiu B., Chan M.M., Fong D., Sinko P.J., Leibowitz M.J., et al. Conjugates bearing multiple formyl-methionyl peptides display enhanced binding to but not activation of phagocytic cells. Bioconjugate Chem 13 2 (2002) 216-223
19. Wan L., Pooyan S., Hu P., Leibowitz M.J., Stein S., and Sinko P.J. Peritoneal macrophage uptake, pharmacokinetics and biodistribution of macrophage-targeted PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarriers for improving HIV drug delivery. Pharm Res 24 11 (2007) 2110-2119
20. Wan L., Zhang X., Pooyan S., Palombo M.S., Leibowitz M.J., Stein S., et al. Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages. Bioconjugate Chem 19 1 (2008) 28-38
21. Nakai T., Kanamori T., Sando S., and Aoyama Y. Remarkably size-regulated cell invasion by artificial viruses. Saccharide-dependent self-aggregation of glycoviruses and its consequences in glycoviral gene delivery. J Am Chem Soc 125 28 (2003) 8465-8475
22. Osaki F., Kanamori T., Sando S., Sera T., and Aoyama Y. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J Am Chem Soc 126 21 (2004) 6520-6521
23. Desai M.P., Labhasetwar V., Walter E., Levy R.J., and Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14 11 (1997) 1568-1573
24. Prabha S., Zhou W.Z., Panyam J., and Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm 244 1-2 (2002) 105-115
25. Roberts M.J., Bentley M.D., and Harris J.M. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54 4 (2002) 459-476
26. Monfardini C., Schiavon O., Caliceti P., Morpurgo M., Harris J.M., and Veronese F.M. A branched monomethoxypoly(ethylene glycol) for protein modification. Bioconjugate Chem 6 1 (1995) 62-69
27. Veronese F.M., Monfardini C., Caliceti P., Schiavon O., Scrawen M.D., and Beer D. Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethylene glycol). J Controlled Release 40 3 (1996) 199-209
28. Yamasaki N., Matsuo A., and Isobe H. Novel polyethylene glycol derivatives for modification of proteins. Agric Biol Chem 52 8 (1988) 2125-2127
29. Veronese F.M., Caliceti P., and Schiavon O. Branched and linear poly(ethylene glycol): influence of the polymer structure on enzymological, pharmacokinetic, and immunological properties of protein conjugates. J Bioact Compat Polym 12 3 (1997) 196
30. Caliceti P., Schiavon O., and Veronese F.M. Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers. Bioconjugate Chem 10 4 (1999) 638-646
31. Caliceti P., Schiavon O., and Veronese F.M. Immunological properties of uricase conjugated to neutral soluble polymers. Bioconjugate Chem 12 4 (2001) 515-522
32. Sarin V.K., Kent S.B., Tam J.P., and Merrifield R.B. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem 117 1 (1981) 147-157
33. Grassetti D.R., and Murray Jr. J.F. Determination of sulfhydryl groups with 2,2′- or 4,4′-dithiodipyridine. Arch Biochem Biophys 119 1 (1967) 41-49
34. Huang S.Y., Pooyan S., Wang J., Choudhury I., Leibowitz M.J., and Stein S. A polyethylene glycol copolymer for carrying and releasing multiple copies of cysteine-containing peptides. Bioconjugate Chem 9 5 (1998) 612-617
35. Zhang X., Jin Y., Plummer M., Pooyan S., Gunaseelan S., and Sinko P. Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro inverso Tat cell penetrating peptide. Mol Pharmaceutics 6 3 (2009) 836-848
36. Udenfriend S., Stein S., Bohlen P., Dairman W., Leimgruber W., and Weigele M. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178 63 (1972) 871-872
37. Veronese F.M. Peptide and protein PEGylation a review of problems and solutions. Biomaterials 22 5 (2001) 405-417
38. Fee C.J. Size comparison between proteins PEGylated with branched and linear poly(ethylene glycol) molecules. Biotechnol Bioeng 98 4 (2007) 725-731
39. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 51 2 (1991) 155-194
40. Meister A., Griffith O.W., Novogrodsky A., and Tate S.S. New aspects of glutathione metabolism and translocation in mammals. Ciba Found Symp 72 (1979) 135-161
41. Goff D.A., and Carroll S.F. Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stability. Bioconjugate Chem 1 6 (1990) 381-386
42. Trimble S.P., Marquardt D., and Anderson D.C. Use of designed peptide linkers and recombinant hemoglobin mutants for drug delivery: in vitro release of an angiotensin II analog and kinetic modeling of delivery. Bioconjugate Chem 8 3 (1997) 416-423